Critério da Associação Brasileira de Nutrologia para diagnóstico e tratamento da síndrome metabólica em crianças e adolescentes

• Autor(a) principal: Nogueira-de-Almeida, Carlos Alberto
• Data de Publicação: 2022
• Outros Autores: Hirose, Thiago Santos, Zorzo, Renato Augusto, Vilanova, Karla Cristina Malta, Ribas Filho, Durval
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: International Journal of Nutrology (Online)
• Texto Completo: https://ijn.zotarellifilhoscientificworks.com/index.php/ijn/article/view/200
• topic: obesity; metabolic syndrome; children; adolescents; consensus

Introduction: Metabolic Syndrome is a set of biochemical, physiological, clinical and metabolic factors that start with peripheral insulin resistance and that, when concomitantly present, increase the risk of developing atherosclerosis, cardiovascular events, type 2 diabetes mellitus and mortality from any cause. In children, there is no consensus on diagnostic criteria and treatment, so the importance of their establishment and standardization. Objective: To publish a consensus of the Brazilian Association of Nutrology for the diagnosis and treatment of Metabolic Syndrome in children and adolescents. Methods: Literature review and discussion among authors. Results: For diagnosis, it is recommended to use the following parameters: excess body adiposity, dyslipidemia, alteration of glycemic-insulinemic profile and elevation of blood pressure. Adolescents and children aged seven years or older will be diagnosed with metabolic syndrome if present altered values in at least 3 of the 4 criteria. Lifestyle modifications, improvement in the quantity and quality of food and increased physical activity are used as initial therapy and the use of metformin is indicated for the control of insulin resistance when those strategies will be not sufficient. Liraglutide can be used in people over 12 years of age to promote weight loss and bariatric surgery is reserved for special cases of severe obesity. Conclusion: Early recognition and treatment of Metabolic Syndrome among children and adolescents provide prevention of cardiovascular adverse events and diabetes in patients and improves their quality of life and the present consensus seeks to standardize these conducts.